Productive virus infection requires evasion, inhibition, or subversion of innate immune responses. West Nile virus (WNV), a human pathogen that can cause symptomatic infections associated with meningitis and encephalitis, inhibits the interferon (IFN) signal transduction pathway by preventing phosphorylation of Janus kinases and STAT transcription factors. Inhibition of the IFN signal cascade abrogates activation of IFN-induced genes, thus attenuating an antiviral response. We investigated the mechanism responsible for this inhibition and found that WNV infection prevents accumulation of the IFN-α receptor subunit 1 (IFNAR1). The WNV-induced depletion of IFNAR1 was conserved across multiple cell types. Our results indicated that expression of WNV nonstructural proteins resulted in activated lysosomal and proteasomal protein degradation pathways independent of the unfolded protein response (UPR). Furthermore, WNV infection did not induce serine phosphorylation, a modification on IFNAR1 that precedes its natural turnover. These data demonstrate that WNV infection results in a reduction of IFNAR1 protein through a non-canonical protein degradation pathway, and may participate in the inhibition of the IFN response.
Get full access to this article
View all access options for this article.
References
1.
AshourJ, Laurent-RolleM, ShiOY, Garcia-SastreA. NS5 of dengue virus mediates STAT2 binding and degradation. J Virol, 2009; 83:5408–5418.
2.
BaconC, McVicarDW, OrtaldoJR, ReesRC, O'SheaJJ, JohnstonJA. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and Tyk2: differential use of Janus family tyrosine kinases by IL-2 and IL-12. J Exp Med, 1995; 181:399–404.
3.
BaillyF, SiN, SiA, TrepoC. Treatment of HCV liver disease by recombinant interferon alpha. Nephrol Dial Transplant, 1996; 11,Suppl 4:56–57.
4.
BestSM, MorrisKL, ShannonJGet al.Inhibition of interferon-stimulated JAK-STAT signaling by a tick-borne flavivirus and identification of NS5 as an interferon antagonist. J Virol, 2005; 79:12828–12839.
5.
BrintonMA. The molecular biology of West Nile Virus: a new invader of the Western hemisphere. Annu Rev Microbiol, 2002; 56:371–402.
6.
ByrneS, HallidayGM, JohnstonLJ, KingNJ. Interleukin-1 beta but not tumor necrosis factor is involved in West Nile virus-induced Langerhans cell migration from the skin in C57BL/6 mice. J Invest Dermatol, 2001; 117:702–709.
7.
CheeAV, RoizmanB. Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites. J Virol, 2004; 78:4185–4196.
8.
ColamoniciO, YanH, DomanskiPet al.Direct binding to and tyrosine phosphorylation of the alpha subunit of the type I interferon receptor by p135tyk2 tyrosine kinase. Mol Cell Biol, 1994; 14:8133–8142.
9.
ColamoniciOR, UyttendaeleH, DomanskiP, YanH, KrolewskiJJ. p135tyk2, an interferon-alpha-activated tyrosine kinase, is physically associated with an interferon-alpha receptor. J Biol Chem, 1994; 269:3518–3522.
10.
ConstantinescuSN, CrozeE, MurtiAet al.Expression and signaling specificity of the IFNAR chain of the type I interferon receptor complex. Proc Natl Acad Sci USA, 1995; 92:10487–10491.
11.
DomanskiP, FishE, NadeauOW, WitteM, PlataniasLC, YanH, KrolewskiJ, PithaP, ColamoniciOR. A region of the beta subunit of the interferon alpha receptor different from box 1 interacts with Jak1 and is sufficient to activate the Jak-Stat pathway and induce an antiviral state. J Biol Chem, 1997; 272:26388–26393.
12.
EmenyJM, MorganMJ. Regulation of the interferon system: evidence that Vero cells have a genetic defect in interferon production. J Gen Virol, 1979; 43:247–252.
13.
EvansJD, SeegerC. Differential effects of mutations in NS4B on West Nile virus replication and inhibition of interferon signaling. J Virol, 2007; 81:11809–11816.
14.
FestiD, SandriL, MazzellaGet al.Safety of interferon beta treatment for chronic HCV hepatitis. World J Gastroenterol, 2004; 10:12–16.
15.
FredericksenBL, GaleMJr. West Nile virus evades activation of interferon regulatory factor 3 through RIG-I-dependent and -independent pathways without antagonizing host defense signaling. J Virol, 2006; 80:2913–2923.
16.
GauzziMC, VelazquezL, McKendryR, MogensenKE, FellousM, PellegriniS. Interferon-alpha-dependent activation of Tyk2 requires phosphorylation of positive regulatory tyrosines by another kinase. J Biol Chem, 1996; 271:20494–20500.
17.
GranwehrBP, LillibridgeKM, HiggsS, MasonPW, AronsonJF, CampbellGA, BarrettAD. West Nile virus: where are we now?Lancet Infect Dis, 2004; 4:547–556.
18.
GublerDJ. The continuing spread of West Nile virus in the Western hemisphere. Clin Infect Dis, 2007; 45:1039–1046.
19.
GuoJT, HayashiJ, SeegerC. West Nile virus inhibits the signal transduction pathway of alpha interferon. J Virol, 2005; 79:1343–1350.
20.
HayesEB, SejvarJJ, ZakiSR, LanciottiRS, BodeAV, CampbellGL. Virology, pathology, and clinical manifestations of West Nile virus disease. Emerg Infect Dis, 2005; 11:1174–1179.
21.
HorvathCM. Weapons of STAT destruction. Interferon evasion by paramyxovirus V protein. Eur J Biochem, 2004; 271:4621–4628.
22.
JiangD, WeidnerJM, QingMet al.Identification of five interferon-induced cellular proteins that inhibit West Nile virus and dengue virus infections. J Virol, 2010; 84:8332–8341.
23.
KaleemA, AhmadI, HoessliDC, Walker-NasirE, SaleemM, ShakooriAR, Nasir UdD. Epidermal growth factor receptors: function modulation by phosphorylation and glycosylation interplay. Mol Biol Rep, 2009; 36:631–639.
24.
KimR, EmiM, TanabeK, MurakamiS. Role of the unfolded protein response in cell death. Apoptosis, 2006p. 11:5–13.
25.
KumarK, VarheseB, BanerjeeA, BakerDP, ConstantinescuSN, PellegriniS, FuchsSY. Basal ubiquitin-independent internalization of interferon alpha receptor is prevented by Tyk2-mediated masking of a linear endocytic motif. J Biol Chem, 2008; 283:18566–18572.
26.
KumarK, BarriereH, CarboneCJet al.Site-specific ubiquitination exposes a linear motif to promote interferon-alpha receptor endocytosis. J Cell Biol, 2007; 179:935–950.
27.
KumarK, KrolewskiJJ, FuchsSY. Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination of the IFNAR1 subunit of type I interferon receptor. J Biol Chem, 2004; 279:46614–46620.
28.
KumarK, TangW, RavindranathAK, ClarkWA, CrozeE, FuchsSY. SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor. EMBO J, 2003; 22:5480–5490.
29.
Laurent-RolleM, BoerEF, LubickKJet al.The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. J Virol, 2010; 84:3503–3515.
30.
LiX, LeungS, KerrIM, StarkGR. Functional subdomains of STAT2 required for preassociation with the alpha interferon receptor and for signaling. Mol Cell Biol, 1997; 17:2048–2056.
31.
LinRJ, ChangBL, YuHP, LiaoCL, LinYL. Blocking of interferon-induced Jak-Stat signaling by Japanese encephalitis virus NS5 through a protein tyrosine phosphatase-mediated mechanism. J Virol, 2006; 80:5908–5918.
32.
LinRJ, LiaoCL, LinE, LinYL. Blocking of the alpha interferon-induced Jak-Stat signaling pathway by Japanese encephalitis virus infection. J Virol, 2004; 78:9285–9294.
LindenbachBD, RiceCM. Flaviviridae: the viruses, their replication. Fields Virology, 4thKnipeHP. Lippincott, Williams, & Wilkins: Philadelphia, 991–1041. 2001.
35.
LingLE, ZafariM, ReardonD, BrickelmeierM, GoelzSE, BenjaminCD. Human type I interferon receptor, IFNAR, is a heavily glycosylated 120-130 kD membrane protein. J Interferon Cytokine Res, 1995; 15:55–61.
36.
LiuJ, HuangFuWC, KumarKGet al.Virus-induced unfolded protein response attenuates antiviral defenses via phosphorylation-dependent degradation of the type I interferon receptor. Cell Host Microbe, 2009; 5:72–83.
37.
LiuWJ, ChenHB, WangXJ, HuangH, KhromykhAA. Analysis of adaptive mutations in Kunjin virus replicon RNA reveals a novel role for the flavivirus nonstructural protein NS2A in inhibition of beta interferon promoter-driven transcription. J Virol, 2004; 78:12225–12235.
38.
LiuWJ, WangXJ, MokhonovVV, ShiPY, RandallR, KhromykhAA. Inhibition of interferon signaling by the New York 99 strain and Kunjin subtype of West Nile virus involves blockage of STAT1 and STAT2 activation by nonstructural proteins. J Virol, 2005; 79:1934–1942.
39.
MarciniakSJ, YunCY, OyadomariSet al.CHOP induces death by promoting protein synthesis and oxidation in the stressed endoplasmic reticulum. Genes Dev, 2004; 18:3066–3077.
MazzonM, JonesM, DavidsonA, ChainB, JacobsM. Dengue virus NS5 inhibits interferon-alpha signaling by blocking signal transducer and activator of transcription 2 phosphorylation. J Infect Dis, 2009; 200:1261–1270.
42.
MedigeshiGR, LancasterAM, HirschAJet al.West Nile virus infection activates the unfolded protein response, leading to CHOP induction and apoptosis. J Virol, 2007; 81:10849–10860.
43.
MillerDM, RahillBM, BossJM, LairmoreMD, DurbinJE, WaldmanJW, SedmakDD. Human cytomegalovirus inhibits major histocompatibility complex class II expression by disruption of the Jak/Stat pathway. J Exp Med, 1998; 187:675–683.
44.
Munoz-JordanJL, Laurent-RolleM, AshourJ, Martinez-SobridoL, AshokM, LipkinWI, Garcia-SastreA. Inhibition of alpha/beta interferon signaling by the NS4B protein of flaviviruses. J Virol, 2005; 79:8004–8013.
45.
Munoz-JordanJL, Sanchez-BurgosGG, Laurent-RolleM, Garcia-SastreA. Inhibition of interferon signaling by dengue virus. Proc Natl Acad Sci USA, 2003; 100:14333–14338.
46.
NisenbaumC, WallisK. Meningo-encephalitis due to West Nile fever. Reports of 2 cases. Helv Paediatr Acta, 1965; 20:392–402.
47.
OyadomariS, MoriM. Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ, 2004; 11:381–389.
48.
ParkGS, MorrisKL, HallettRG, BloomME, BestSM. Identification of residues critical for the interferon antagonist function of Langat virus NS5 reveals a role for the RNA-dependent RNA polymerase domain. J Virol, 2007; 81:6936–6946.
49.
PetersenLR, MarfinAA. West Nile virus: a primer for the clinician. Ann Intern Med, 2002; 137:173–179.
50.
PetersenLR, RoehrigJT, HughesJM. West Nile virus encephalitis. N Engl J Med, 2002; 347:1225–1226.
RichterMF, DumenilG, UzeG, FellousM, PellegriniS. Specific contribution of Tyk2 JH regions to the binding and the expression of the interferon alpha/beta receptor component IFNAR1. J Biol Chem, 1998; 273:24723–24729.
53.
SampsonBA, AmbrosiC, CharlotA, ReiberK, VeressJF, ArmbrustmacherV. The pathology of human West Nile Virus infection. Hum Pathol, 2000; 31:527–531.
54.
SejvarJJ, HaddadMB, TierneyBCet al.Neurologic manifestations and outcome of West Nile virus infection. JAMA, 2003; 290:511–515.
55.
SejvarJJ, LeisAA, StokicDSet al.Acute flaccid paralysis and West Nile virus infection. Emerg Infect Dis, 2003; 9:788–793.
56.
ShiPY, TilgnerM, LoMK, KentKA, BernardKA. Infectious cDNA clone of the epidemic West Nile virus from New York City. J Virol, 2002; 76:5847–5856.
57.
SuHL, LiaoCL, LinYL. Japanese encephalitis virus infection initiates endoplasmic reticulum stress and an unfolded protein response. J Virol, 2002; 76:4162–4171.
WarisG, TardifKD, SiddiquiA. Endoplasmic reticulum (ER) stress: hepatitis C virus induces an ER-nucleus signal transduction pathway and activates NF-kappaB and STAT-3. Biochem Pharmacol, 2002; 64:1425–1430.
60.
YamshchikovVF, WenglerG, PerelyginAA, BrintonMA, CompansRW. An infectious clone of the West Nile flavivirus. Virology, 2001; 281:294–304.
61.
YokotaS, YokosawaN, KubotaTet al.Herpes simplex virus type 1 suppresses the interferon signaling pathway by inhibiting phosphorylation of STATs and janus kinases during an early infection stage. Virology, 2001; 286:119–124.
62.
YuCY, HsuYW, LiaoCL, LinYL. Flavivirus infection activates the XBP1 pathway of the unfolded protein response to cope with endoplasmic reticulum stress. J Virol, 2006; 80:11868–11880.
63.
ZouJ, PreskyDH, WuCY, GublerU. Differential associations between the cytoplasmic regions of the interleukin-12 receptor subunits beta1 and beta2 and JAK kinases. J Biol Chem, 1997; 272:6073–6077.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
